Ioxilan
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Ioxilan is a diagnostic contrast agent.[1] It is injected intravenously before taking X-ray images to increase arterial contrast in the final image. It was marketed in the US under the trade name Oxilan by Guerbet, L.L.C., but was discontinued in 2017.[2]
Mechanism of action
Ioxilan is an iodinated contrast agent.[2]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ a b Oxilan Template:Drugs.com. Accessed 2021-04-07.
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".